AXSM R&D Expenses
Axsome Therapeutics Inc · R&D Expenses
AXSM R&D Expenses
Latest reported$187.86Mperiod ending
AXSM R&D Expenses ($1.54M → $187.86M)
Annual R&D Expenses
High-resolution chart · PNG
AXSM r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 183,279,000 | |
| 187,077,000 | |
| 97,944,000 | |
| 57,947,000 | |
| 58,061,000 | |
| 70,244,579 | |
| 53,647,067 | |
| 23,495,055 | |
| 19,957,616 | |
| 21,199,860 | |
| 6,776,987 | |
| 4,279,200 | |
| 1,535,255 |